ABSTRACT
A mathematical model describing mutually affecting catastrophes is suggested. The hazard and risk are estimated.(AU)
Subject(s)
Disasters , Information Systems , Risk AssessmentABSTRACT
A new sutural material in the form of polyacrylamide threads containing gentamicin in an amount of 10 per cent by the thread weight was studied. After storage for a year under refrigerator conditions the threads preserved their antibacterial activity when studied in vitro. Since gentamicin was included within the threads by means of the ionic links its release from the threads to the environment either in vitro or in vivo was gradual and uniform within at least 10 days. The quantity of the released antibiotic depended on its content per unit of thread length. The marked antibacterial effect within the prolonged period is a basis for the use of the threads in surgical practice for the prevention of infections in the early postoperative period.
Subject(s)
Gentamicins/administration & dosage , Sutures , Delayed-Action Preparations , Humans , Surgical Wound Infection/prevention & controlABSTRACT
We have developed an immunoadsorbent (IA) for ex vivo removal of IgE after in vitro screening of matrix (Sepharose and tresyl-activated Toyopearl) and ligand (monospecific rabbit polyclonal anti-IgE antiserum and monoclonal antibodies (Abs) or their Fab fragments). Specific adsorptive capacity (SAC) for IgE was maximal in Sepharose-based IA with both types of Abs. Fab-containing IA on Sepharose retained 70-90% of the SAC of native Ab-containing IA. Toyopearl-based IA showed comparable SAC under static conditions but worked unsatisfactorily under continuous flow conditions. To assess the complement-activating capacity (CAC) of IA in vitro anaphylatoxin (C3a, C4a, C5a) generation was applied. CAC was directly related with the amount of immobilized Ab ligand, without depending on Ab specific activity. Fab-containing IA showed more CAC than native Ab-containing IA, and polyclonal IA more than monoclonal IA. Therefore, IA for IgE apheresis were prepared from native monoclonal Abs and CNBr-activated Sepharose CL 4B under aseptic conditions and packed into a glass column. This IA was used in 17 clinical IgE apheresis treatments of five atopic asthma patients. No substantial side effects were observed; in vivo IA effectively removed IgE from plasma (83 to 98%).
Subject(s)
Asthma/therapy , Immunoglobulin E , Immunosorbent Techniques , Immunosorbents , Plasma , Polymers , Adult , Asthma/immunology , Blood Component Removal/methods , Humans , Male , PerfusionABSTRACT
Serine proteinase and metalloproteinase of Asp. oryzae, extracellular metalloproteinase of L. pneumophila and chymotrypsin-like proteinase of S. rutgersensis can hydrolyze pepsinogen by converting it into pepsin (pH 5.0, 37 degrees C). The localization of the site of hydrolysis depends on the nature of the enzyme: serine proteinase from Asp. oryzae induces the synthesis of a mixture of 60% pepsin, 25% leucyl-pepsin and 15% alanyl-leucyl-pepsin; metalloproteinase of Asp. oryzae converts pepsinogen only into leucyl-pepsin, while metalloproteinase of L. pneumophila yields a mixture of 33% pepsin, 53% leucyl-pepsin and 14% alanyl-leucyl-pepsin. Thus, the region of the activating pepsinogen peptide--Ala 42P-Ile 1 bond--seems to the most probable site for hydrolysis by exogenous proteinases. This site contains a Leu 44P-Ile 1 bond which is subjected to intermolecular hydrolysis during autocatalytic activation of pepsinogen. The experimental results emphasize the importance of the intermolecular pathway of pepsinogen activation.
Subject(s)
Bacteria/enzymology , Metalloendopeptidases/metabolism , Pepsinogens/metabolism , Serine Endopeptidases/metabolism , Amino Acids/analysis , Animals , Chromatography, DEAE-Cellulose , Hydrolysis , SwineABSTRACT
It was found that at pH 5.2 and 40-fold excess of p-nitrophenyldiazonium chloride the inhibitor incorporation into the porcine pepsin molecule involves 1.9 residues, one residue being bound to tyrosine 189. Besides, tyrosines 44, 113, 154 and 174 enter the reaction. Modified pepsin retains 25% of the native enzyme activity. In the pepsinogen molecule the degree of tyrosine 189 modification diminishes 5 times; of 1.5 inhibitor molecules incorporated into the protein 0.78 residues are bound to tyrosine 113. The potential proteolytic activity of modified pepsinogen towards haemoglobin cleavage makes up to 60% of the original one. It is concluded that the activation peptide in the pepsinogen molecule masks the substrate binding site bearing tyrosine 189, thus preventing its modification with p-nitrophenyldiazonium chloride. The activation peptide in the pepsinogen molecule is presumably located in the vicinity of the wide loop bend carrying tyrosine residue 113, which may be the reason for the decreased pKa value of this residue and of its increased reactivity in the azocoupling reaction.
